|Skystar Bio-Pharm - 3/8/2014|
Skystar Bio-Pharmaceutical's ("SKBI" or "the Company")
This website contains forward-looking statements. The words or phrases "would be," "will allow," "intends to," "will likely result," "are expected to," "will continue," "is anticipated," "estimate," "project," or similar expressions are intended to identify "forward-looking statements." Actual results could differ materially from those projected in Skystar Bio-Pharmaceutical's proposed oil and gas related business. The Company's business is subject to various risks, which are discussed in the Company's filings with the Securities and Exchange Commission ("SEC"). The Company'a filings may be accessed on the SEC's Edgar system at: www.sec.gov. The content of this website is intended for information only and should not be construed by any means as an indication of the value of the Company or its common stock. Statements made herein are as of the publication date of the website and should not be relied upon as of any subsequent date. The Company cautions readers not to place reliance on such statements. Unless otherwise required by applicable law, we do not undertake, and we specifically disclaim any obligation, to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such a statement.
All statements contained herein that are not historical facts, including but not limited to, statements regarding the Company'scurrent business strategy, the Company's projected sources and uses of cash, and the Company's plans for future development and operations, are based upon current expectations. These statements are forward-looking in nature and involve a number of risks and uncertainties. Actual results may differ materially. Among the factors that could cause actual results to differ materially are the following: the availability of sufficient capital to finance the Company's business plans on terms satisfactory to the Company; competitive factors; changes in labor, equipment and capital costs; changes in regulations affecting the Company's business; future acquisitions or strategic partnerships; general business and economic conditions; and factors described from time to time in the reports filed by the Company with the Securities and Exchange Commission. The Company cautions readers not to place undue reliance on any such forward-looking statements, which statements are made pursuant to the Private Litigation Reform Act of 1995 and, as a result, are pertinent only as of the date made.
Skystar Bio-Pharmaceutical(SKBI) cannot guarantee that any hyperlinks which may be included in our website will be accurate at the time of your access. Moreover, the sites pointed at by hyperlinks are developed and possibly maintained by person(s) over whom we have no control. We cannot and do not monitor the sites linked to our pages on the Internet. Accordingly, SKBI assumes no responsibility for the content of any site referenced to by any hyperlink or otherwise. We believe that our making available hyperlinks to publicly accessible web pages and newsgroups is legally permissible and consistent with the common and customary expectations of those who make use of the Internet.